Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by HighteawithIntrepid

PFSCF

RE:FDA changes

Can we buy our FDA stage IV drug back for $100? The doctors liked it and...

June 22, 2017

PFSCF

Sedar

Offering on SEDAR as of June 20 not June 21 and Thomvest will be concurrent...

June 21, 2017

PFSCF

RE:RE:RE:I wonder if the FDA is currently working on...

If we are skipping 6 months of review then the FDA should have hinted that to...

June 21, 2017

PFSCF

Other BB

Eddie the believers are correct that I don't post on other BB, but then...

June 21, 2017

PFSCF

Zero hour

There was no FDA news as of 5:30 today so we are in uncharted waters. Without...

June 20, 2017

PFSCF

RE:RE:RE:RE:RE:RE:RE:Thomvest et al

Sky: you post the positives you see. The deals beyond the $53 million lack...

June 20, 2017

PFSCF

RE:RE:RE:RE:RE:Thomvest et al

Sky: until time proves the deal as over subscribed we are looking at 94% of...

June 20, 2017

PFSCF

RE:RE:RE:Thomvest et al

You do realize that the 61 million deal doesn't mean 61 million in the...

June 20, 2017

PFSCF

Thomvest et al

The question for Fred is: Do the other current large players have an imbedded...

June 20, 2017

PFSCF

June 5 plus 14

So that makes tomorrow a big day. Sky I have said $53 million was dilutive...

June 19, 2017

PFSCF

RE:Manipulation

Eddie switched sides yesterday, Cantor is making sure their private placement...

June 19, 2017

PFSCF

For those with Fred's ear

Please ask Fred why no rights offering at a 1.70. Now that this is a done...

June 19, 2017

PFSCF

RE:should I double down ?

In the land of 100k plus positions your a rounding error so go to 3,000.

June 18, 2017

PFSCF

RE:RE:RE:RE:So, watcha gonna do?

Wow we are all sucking the hind tit here and you show no compassion to those...

June 18, 2017

PFSCF

1 for 20 rights offering

Eddie now that you have switched teams what are your thoughts on a 1 for 20...

June 18, 2017

PFSCF

RE:So, watcha gonna do?

Buy a 649 ticket and if I win big buy more. I sold the big part of TST at 2...

June 18, 2017

PFSCF

RE:RE:Response from Pierre to my questions.

Eddy: your sounding like you covered your shorts Friday and went long at 1.65...

June 18, 2017

PFSCF

RE:Financing takes on different perspective.....

sah1: So he did use weasel words, therefore he technically  didn't...

June 18, 2017

PFSCF

2.98 vs 1.7 minus 6 points

1) That is dilutive to the conscripts  2) deals take about 90 days to...

June 18, 2017

PFSCF

June 5 plus 13

Reality bites. Still mad that they didn't do a rights offering but until...

June 18, 2017

Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next

Featured Company

Biosenta Inc.

Biosenta Inc. C.ZRO

Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and ... view more »